References

Targeting the notch signaling pathway and the notch ligand, DLL3, in small cell lung cancer

10.1016/j.biopha.2023.114248 · 2023 · External reference

Efficacy and safety of anlotinib maintenance therapy in limited-stage small cell lung cancer

10.1007/s12672-025-03895-0 · 2025 · External reference

Real-life clinical management patterns in extensive-stage small cell lung cancer across France: A multi-method study

10.1186/s12885-024-12117-9 · 2024 · External reference

Comparison of atezolizumab, durvalumab, pembrolizumab, and nivolumab as first-line treatment in patients with extensive-stage small cell lung cancer: A systematic review and network meta-analysis

10.1097/md.0000000000025180 · 2021 · External reference

HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy

10.1016/j.jare.2023.12.020 · 2024 · External reference

Small cell lung cancer: A review

10.1001/jama.2025.0560 · 2025 · External reference

Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia

10.3390/cancers12051081 · 2020 · External reference

Diagnosis and treatment of therapy-related acute myeloid leukemia

10.1016/j.critrevonc.2022.103607 · 2022 · External reference

Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML

10.1186/s13045-021-01119-w · 2021 · External reference

Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia

10.1016/j.cbi.2009.11.025 · 2010 · External reference

Therapy-related myelodysplastic syndromes and acute myeloid leukemia

10.1053/j.seminhematol.2024.09.004 · 2024 · External reference

Secondary neoplasm in survivors of childhood hematological malignancies-systematic review

2026 · External reference

Very early onset of therapy-related acute myeloid leukemia with 11q23 rearrangement presenting with unusual PET findings after R-DA-EPOCH for primary mediastinal large B-cell lymphoma

10.3390/medicina58010048 · 2021 · External reference

Introduction and interpretation of the updated contents of the International System for Human Cytogenomic Nomenclature

2021 · External reference

A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer

10.1038/s41392-024-02115-5 · 2025 · External reference

Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer

10.1002/ccr3.1931 · 2019 · External reference

ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer

10.1126/sciadv.ado4618 · 2024 · External reference

Rare cytogenetic abnormalities and their clinical relevance in pediatric acute leukemia of Saudi Arabian population

10.1186/s13039-019-0454-0 · 2019 · External reference

A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia

10.1016/j.cancergencyto.2003.07.002 · 2004 · External reference

Generation of the NUP98-TOP1 fusion transcript by the t(11;20) (p15;q11) in a case of acute monocytic leukemia

10.1016/s0165-4608(02)00642-8 · 2003 · External reference

Both NUP98/TOP1 and TOP1/NUP98 transcripts are detected in a de novo AML with t(11;20)(p15;q11)

10.1002/gcc.10239 · 2003 · External reference

HOXA9 transcription factor is a double-edged sword: From development to cancer progression

10.1007/s10555-023-10159-2 · 2024 · External reference

The fusion partner specifies the oncogenic potential of NUP98 fusion proteins

10.1016/j.leukres.2013.09.013 · 2013 · External reference

Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: Exploratory biomarker analysis of the randomized, phase 2 DESTINY-gastric01 trial

10.1038/s41591-024-02992-x · 2024 · External reference

NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis

10.1016/j.ccell.2016.10.019 · 2016 · External reference

Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma

10.3324/haematol.2020.269944 · 2022 · External reference

Recurrent translocations in topoisomerase inhibitor-related leukemia are determined by the features of DNA breaks rather than by the proximity of the translocating genes

10.3390/ijms23179824 · 2022 · External reference

Progress toward better treatment of therapy-related AML

10.3390/cancers15061658 · 2023 · External reference

Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs

10.3390/pharmaceutics13030365 · 2021 · External reference

DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol

10.1016/j.mrrev.2021.108409 · 2022 · External reference

The relation between cigarette smoking and risk of acute myeloid leukemia: An updated meta-analysis of epidemiological studies

10.1002/ajh.23744 · 2014 · External reference

Cigarette smoke exposure accelerates AML progression in FLT3-ITD models

10.1182/bloodadvances.2023010111 · 2023 · External reference